Phase 1 clinical trial of a novel proteasome inhibitor (NPI-0052) in patients with lymphomas and solid tumors Meeting Abstract


Authors: Kurzrock, R.; Hamlin, P.; Younes, A.; Hong, D.; Gordon, M.; Spear, M. A.; Palladino, M. A.; Lloyd, G. K.; Longenecker, A. M.; Neuteboom, S. T. C.; Cropp, G. F.; Hannah, A.; Aghajanian, C.
Abstract Title: Phase 1 clinical trial of a novel proteasome inhibitor (NPI-0052) in patients with lymphomas and solid tumors
Meeting Title: 49th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 110
Issue: 11 Pt. 2
Meeting Dates: 2007 Dec 8-11
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2007-11-01
Start Page: 198B
Language: English
ACCESSION: WOS:000251101101275
PROVIDER: wos
PUBMED: 18092370
Notes: --- - Meeting Abstract: 4504 - 49th Annual Meeting of the American-Society-of-Hematology - DEC 08-11, 2007 - Atlanta, GA - Part 2 - "Source: Wos"
MSK Authors
  1. Paul Hamlin
    168 Hamlin